Nutritional and functional outcomes in trials of nutrient-stimulated hormone-based therapy-A systematic mapping review.

IF 8 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Obesity Reviews Pub Date : 2025-01-27 DOI:10.1111/obr.13890
Sébastien Czernichow, Nathalie Rassy, Claire Carette, Nicholas Shoung, Frank B Hu, Claire Rives-Lange
{"title":"Nutritional and functional outcomes in trials of nutrient-stimulated hormone-based therapy-A systematic mapping review.","authors":"Sébastien Czernichow, Nathalie Rassy, Claire Carette, Nicholas Shoung, Frank B Hu, Claire Rives-Lange","doi":"10.1111/obr.13890","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Currently, trials are investigating the efficacy of nutrient-stimulated hormone-based therapies (NuSHs) in promoting weight loss in people living with overweight and obesity. However, the extent to which nutritional and functional outcomes are evaluated remains uncertain. Thus, we conducted a systematic mapping to assess the presence of nutritional and functional outcomes in randomized controlled trials (RCTs) investigating NuSHs.</p><p><strong>Methods: </strong>We conducted a systematic mapping search on the Cochrane Central Register of Controlled Trials (CENTRAL), which includes ClinicalTrials.gov and the International Clinical Trials Registry Platform for interventional trials of NuSHs registered from inception to December 31, 2023. We excluded non- and quasi-randomized trials, phase I trials, trials that did not include body weight as a primary or secondary outcome, trials with an intervention duration of less than 6 months, and trials that did not specify a body mass index threshold in their eligibility criteria. Outcomes included: dietary intake, eating behavior, body composition, physical performance, muscle strength, bone health, and levels of vitamins, trace elements, albumin, prealbumin, and hemoglobin.</p><p><strong>Results: </strong>The search identified 2284 trials, of which 417 were included in the analysis. The proportion of RCTs that included nutritional assessment other than body weight increased over time. Approximately, 20.4% reported measurements of body composition, 17.3% reported measurements of albumin/prealbumin/hemoglobin, and 17% reported assessment of dietary intake and eating behavior. Evaluations of bone health, physical performance, muscle strength, and measurements of vitamins/trace elements were reported in less than 5% of the total trials each.</p><p><strong>Conclusion: </strong>The present review has shown the sparse reporting of nutritional and functional outcomes in RCTs evaluating the impact of NuSHs.</p>","PeriodicalId":216,"journal":{"name":"Obesity Reviews","volume":" ","pages":"e13890"},"PeriodicalIF":8.0000,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity Reviews","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/obr.13890","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Currently, trials are investigating the efficacy of nutrient-stimulated hormone-based therapies (NuSHs) in promoting weight loss in people living with overweight and obesity. However, the extent to which nutritional and functional outcomes are evaluated remains uncertain. Thus, we conducted a systematic mapping to assess the presence of nutritional and functional outcomes in randomized controlled trials (RCTs) investigating NuSHs.

Methods: We conducted a systematic mapping search on the Cochrane Central Register of Controlled Trials (CENTRAL), which includes ClinicalTrials.gov and the International Clinical Trials Registry Platform for interventional trials of NuSHs registered from inception to December 31, 2023. We excluded non- and quasi-randomized trials, phase I trials, trials that did not include body weight as a primary or secondary outcome, trials with an intervention duration of less than 6 months, and trials that did not specify a body mass index threshold in their eligibility criteria. Outcomes included: dietary intake, eating behavior, body composition, physical performance, muscle strength, bone health, and levels of vitamins, trace elements, albumin, prealbumin, and hemoglobin.

Results: The search identified 2284 trials, of which 417 were included in the analysis. The proportion of RCTs that included nutritional assessment other than body weight increased over time. Approximately, 20.4% reported measurements of body composition, 17.3% reported measurements of albumin/prealbumin/hemoglobin, and 17% reported assessment of dietary intake and eating behavior. Evaluations of bone health, physical performance, muscle strength, and measurements of vitamins/trace elements were reported in less than 5% of the total trials each.

Conclusion: The present review has shown the sparse reporting of nutritional and functional outcomes in RCTs evaluating the impact of NuSHs.

导言:目前,正在对营养刺激荷尔蒙疗法(NuSHs)在促进超重和肥胖症患者减轻体重方面的疗效进行试验研究。然而,对营养和功能结果的评估程度仍不确定。因此,我们进行了一项系统性摸底调查,以评估研究 NuSHs 的随机对照试验(RCT)中是否存在营养和功能方面的结果:我们在科克伦对照试验中央登记册(CENTRAL)上进行了系统性映射检索,该登记册包括ClinicalTrials.gov和国际临床试验登记平台(International Clinical Trials Registry Platform),用于检索从开始到2023年12月31日期间登记的NuSHs干预性试验。我们排除了非随机和准随机试验、I 期试验、未将体重作为主要或次要结果的试验、干预时间少于 6 个月的试验以及资格标准中未规定体重指数阈值的试验。结果包括:饮食摄入量、饮食行为、身体成分、身体表现、肌肉力量、骨骼健康以及维生素、微量元素、白蛋白、前白蛋白和血红蛋白水平:搜索发现了 2284 项试验,其中 417 项被纳入分析。除体重外,纳入营养评估的研究性试验比例随着时间的推移而增加。约有 20.4% 的研究报告了对身体成分的测量,17.3% 的研究报告了对白蛋白/白蛋白/血红蛋白的测量,17% 的研究报告了对饮食摄入量和饮食行为的评估。对骨骼健康、体能表现、肌肉力量以及维生素/微量元素测量进行评估的试验分别不到试验总数的 5%:本综述表明,在评估 NuSHs 影响的 RCT 中,营养和功能结果的报告很少。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Obesity Reviews
Obesity Reviews 医学-内分泌学与代谢
CiteScore
19.30
自引率
1.10%
发文量
130
审稿时长
1 months
期刊介绍: Obesity Reviews is a monthly journal publishing reviews on all disciplines related to obesity and its comorbidities. This includes basic and behavioral sciences, clinical treatment and outcomes, epidemiology, prevention and public health. The journal should, therefore, appeal to all professionals with an interest in obesity and its comorbidities. Review types may include systematic narrative reviews, quantitative meta-analyses and narrative reviews but all must offer new insights, critical or novel perspectives that will enhance the state of knowledge in the field. The editorial policy is to publish high quality peer-reviewed manuscripts that provide needed new insight into all aspects of obesity and its related comorbidities while minimizing the period between submission and publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信